News AbbVie files fast-acting Botox successor in US AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with a short-acting successor to its blockbuster Botox brand.
Market Access Therapeutic or cosmetic? Patent strategies for dual-use inno... In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.
Events Partner Content Your Ultimate Guide To The Skin Microbiome Your Ultimate Guide To The Skin Microbiome
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.